| Titolo |
Pubblicato in |
Anno |
| Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases |
JOURNAL OF CARDIOVASCULAR MEDICINE |
2025 |
| Prognostic impact of hypertension and diabetes in patients with cardiac amyloidosis |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2025 |
| Exploring Cardiac Sympathetic Denervation in Transthyretin-Mediated Hereditary Amyloidosis (ATTRv): Insights from 123I-mIBG Scintigraphy |
DIAGNOSTICS |
2025 |
| Critical approach to the 2023 European Society of Cardiology guidelines on cardiomyopathies: a document by the Working Group on Myocardial and Pericardial Diseases of the Italian Society of Cardiology |
JOURNAL OF CARDIOVASCULAR MEDICINE |
2025 |
| Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2024 |
| Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Incident Cancer |
HEART LUNG & CIRCULATION |
2024 |
| Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry |
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE |
2024 |
| Neurological Disorders in Takotsubo Syndrome: Clinical Phenotypes and Outcomes |
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE |
2024 |
| Statin therapy and outcome in Takotsubo syndrome patients: Results from the multicenter international GEIST registry |
ATHEROSCLEROSIS |
2024 |
| Advanced Cardiovascular Magnetic Resonance Imaging in Takotsubo Syndrome: Update on Feature Tracking and Tissue Mapping |
CURRENT CARDIOVASCULAR IMAGING REPORTS |
2024 |
| Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis |
EUROPEAN JOURNAL OF HEART FAILURE |
2024 |
| Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based Analysis |
JACC. ADVANCES |
2024 |
| Re-analysis of Next-generation Sequencing Data in Patients with Hypertrophic Cardiomyopathy: Contribution of Spliceogenic MYBPC3 Variants in an Italian Cohort |
ANNALS OF LABORATORY MEDICINE |
2024 |
| Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study |
ESC HEART FAILURE |
2024 |
| Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis |
JACC. ADVANCES |
2024 |
| Renin angiotensin system inhibitors and outcome in patients with takotsubo syndrome: A propensity score analysis of the GEIST registry |
AMERICAN HEART JOURNAL |
2024 |
| Clinical characteristics and outcomes of Takotsubo syndrome in patients with chronic obstructive pulmonary disease |
EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2024 |
| SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy |
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
2024 |
| Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study |
ESC HEART FAILURE |
2024 |
| Prognostic impact of different triggers in patients with Takotsubo syndrome and chronic obstructive pulmonary disease. Author's reply |
EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2024 |
